Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0050 (7.14%)
Sep 17, 2026, 5:16 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 25.47 million as of September 18, 2026. Its market cap has increased by 114.25% in one year.
Market Cap
25.47M
Enterprise Value
21.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 25.47M, an increase of 46.25%. That is a compound annual growth rate of 5.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 25.47M | 110.00% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 37.38M |
| Defence Therapeutics | 37.14M |
| Telescope Innovations | 36.17M |
| Thiogenesis Therapeutics | 34.99M |
| Resverlogix | 30.99M |
| Onco-Innovations | 29.37M |
| Pharmala Biotech Holdings | 29.07M |